Sponsor Pipeline

Jubilant Therapeutics India Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07755397 First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety… Phase 1 Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07755397 First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety… NSCLC Patients With EGFR Activating Mutation Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1)
Get alerts when Jubilant Therapeutics India Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free